Email This Article

Headlines & Perspectives
Study Cites Anemia Drug Risks
By Elizabeth Trotta
10/01/08 - 01:06 PM EDT
Amgen's Aranesp and Johnson & Johnson's Procrit may increase the risk of death in cancer patients and lower overall survival.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,367.44 1,107.32 2,192.39 33.99
Oil *
76.96
UP
96.97
UP
13.84
UP
24.51
DOWN
0.30
10 Yr
3.40%
SPDR Gold
110.70
+0.94%
+1.27%
+1.13%
-0.87%
Data delayed 20 minutes

Brokerage Partners